
Greenrose Acquisition Corp.
Greenrose Acquisition Corp. (GNRSW) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNRSW · as of Jun 9, 2026
Key Statistics
Explore Greenrose Acquisition Corp. Data
gnrsw stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gnrsw competitorsStock Performance
Full HistoryAbout Greenrose Acquisition Corp.
Greenrose Acquisition Corp. Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing…
what is greenrose acquisition corp. · gnrsw stock overview · greenrose acquisition corp. company profile · who is greenrose acquisition corp. ceo · gnrsw OTC · greenrose acquisition corp. headquarters · greenrose acquisition corp. business segments
About Stock Overview & Key Data
Greenrose Acquisition Corp. (GNRSW) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since May 11, 2020. As of the latest trading session, GNRSW stock price is $0.00, with a market capitalization of $1,768. The stock has returned -100.00% over the past 12 months and -99.00% year-to-date.
In fiscal year 2021, Greenrose Acquisition Corp. reported revenue of $25.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Greenrose Acquisition Corp. (GNRSW) stock price is $0.00. The stock is traded on OTC under the ticker symbol GNRSW. The 52-week range is $1.00 – $6.00.